BTI
IART icon

Blue Trust Inc’s Integra LifeSciences IART Stock Holding History

Blue Trust Inc’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.7K Buy
1,765
+368
+26% +$5.15K ﹤0.01% 1520
2026
Q1 		$13.2K Sell
1,397
-13
-0.9% -$143 ﹤0.01% 1771
2025
Q4 		$17.5K Sell
1,410
-593
-30% -$7.88K ﹤0.01% 1726
2025
Q3 		$28.7K Buy
2,003
+594
+42% +$8.14K ﹤0.01% 1573
2025
Q2 		$17.3K Buy
1,409
+14
+1% +$203 ﹤0.01% 1724
2025
Q1 		$30.7K Buy
1,395
+459
+49% +$10.8K ﹤0.01% 1546
2024
Q4 		$21.2K Buy
936
+590
+171% +$12.9K ﹤0.01% 1586
2024
Q3 		$10.1K Sell
346
-540
-61% -$12.5K ﹤0.01% 2188
2024
Q2 		$31.4K Buy
886
+444
+100% +$13.2K ﹤0.01% 1469
2024
Q1 		$15.7K Sell
442
-132
-23% -$5.28K ﹤0.01% 1318
2023
Q4 		$22K Buy
574
+71
+14% +$2.79K ﹤0.01% 1241
2023
Q3 		$21K Buy
503
+230
+84% +$9.68K ﹤0.01% 1157
2023
Q2 		$16K Sell
273
-1,752
-87% -$84.3K ﹤0.01% 1132
2023
Q1 		$113K Buy
2,025
+1,384
+216% +$78K ﹤0.01% 730
2022
Q4 		$27K Buy
641
+347
+118% +$17.7K ﹤0.01% 1178
2022
Q3 		$16K Buy
294
+102
+53% +$5.23K ﹤0.01% 1176
2022
Q2 		$12K Buy
+192
New +$11.5K ﹤0.01% 1140

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Blue Trust Inc's IART Position: Q2 2026 in Review

Blue Trust Inc increased its Integra LifeSciences (IART) stake by 26% in Q2 2026, buying an estimated $5.15K and bringing the position to 1,765 shares worth $31.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1520.

Blue Trust Inc first reported a position in IART in Q2 2022 and has held it in 17 quarters since. The position peaked at $113K in Q1 2023. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Blue Trust Inc held 1,765 shares of Integra LifeSciences worth $31.7K as of Q2 2026.
  • Blue Trust Inc bought 368 Integra LifeSciences shares in Q2 2026, an estimated $5.15K.
  • Integra LifeSciences made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1520 holding.
  • Blue Trust Inc first reported a position in Integra LifeSciences in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Integra LifeSciences position peaked at $113K in Q1 2023.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.